Next Article in Journal
A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients’ Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece
Next Article in Special Issue
Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47
Previous Article in Journal
The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers
 
 
Article

Article Versions Notes

Cancers 2022, 14(8), 1878; https://doi.org/10.3390/cancers14081878
Action Date Notes Link
article html file updated 27 December 2025 06:27 CET Update https://www.mdpi.com/2072-6694/14/8/1878/html
article html file updated 10 September 2025 14:35 CEST Update -
article html file updated 2 August 2022 17:49 CEST Update -
article html file updated 11 April 2022 08:20 CEST Update -
article pdf uploaded. 11 April 2022 08:19 CEST Updated version of record https://www.mdpi.com/2072-6694/14/8/1878/pdf
article xml uploaded. 11 April 2022 08:19 CEST Update https://www.mdpi.com/2072-6694/14/8/1878/xml
article xml file uploaded 11 April 2022 08:19 CEST Update -
article html file updated 8 April 2022 09:32 CEST Original file -
article supplementary file uploaded. 8 April 2022 09:30 CEST - https://www.mdpi.com/2072-6694/14/8/1878#supplementary
article pdf uploaded. 8 April 2022 09:30 CEST Version of Record https://www.mdpi.com/2072-6694/14/8/1878/pdf-vor
article xml uploaded. 8 April 2022 09:30 CEST Update -
article xml file uploaded 8 April 2022 09:30 CEST Original file -
Back to TopTop